PATENT CLAIM ANALYSIS

Application Number: 16529400
Application Type: Utility
Filing Date: 2019-08
Publication Date: 2019-11
Patent Classification: ["514", "401000"]

Abstract:
Disclosed is a single unit oral dosage form having, in combination, inositol and an extended release clonidine or extended release guanfacine. In one aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient the single unit oral dosage form. In another aspect, a method for treating ADHD and/or associated symptoms thereof includes administering to an ADHD patient inositol in combination with extended release clonidine or extended release guanfacine, whether administered separately or as a single dosage form.

Claim (Index 30):
The method of  claim 21  comprising administering only one of the dosage forms per day, wherein the inositol is present in the dosage form in an amount of from 12,000 mg to 32,400 mg.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 100.0
- Lexical Diversity: 2.11628
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14245121', '13860824', '15346079', '13656415', '15102871']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7697813204008163
- 35 USC 102 Novelty (BERT): 0.568035395288041
- Combined Prediction Score: 0.7496067278895387
- Mean Citation Score: 386.91969
- Max Citation Score: 559.2398
- Similarity Product: 329.2189682938814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test